Mature bone marrow-derived dendritic cells polarize Th2 response and suppress experimental autoimmune encephalomyelitis

Multiple Sclerosis

Volumn 8, Issue 6, 2002, Pages 463-468

  Zhang, G X ^a   Kishi, M ^a   Xu, H ^a   Rostami, A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokines; Dendritic cells; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Th1 Th2

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL MARKER; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; HLA ANTIGEN CLASS 2;

ADHERENT CELL; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DENDRITIC CELL; DISEASE SEVERITY; FEMALE; IMMUNIZATION; INFLAMMATION; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; POLARIZATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL SEPARATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; PATHOLOGY;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOPHENOTYPING; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; TH2 CELLS;

EID: 0036892829     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms857oa     Document Type: Article

References (45)

1. Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P. The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy. Clin Exp Allergy 1999; 29(Suppl 2): 33-36
2. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1995; 144: 245-68
3. Trinchieri G. Interleukin-12: A cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70: 83-243
4. Leonard JP, Waldburger KE, Goldman SG. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 1995; 181: 381-86
5. Xu H, Zhang GX, Wysocka M et al. The suppressive effect of TGF-beta on IL-12-mediated immune modulation specific to a peptide Ac1-11 of myelin basic protein (MBP): A mechanism involved in inhibition of both IL-12 receptor beta1 and beta2. J Neuroimmunol 2000; 108: 53-63
6. Constantinescu CS, Wysocka M, Hilliard H, et al. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 1998; 161: 5097-5104
7. Abromson-Leeman S, Maverakis E, Bronson R, Dorf E. CD40-mediated activation of T cells accelerates, but is not required for, encephalitogenic potential of myelin basic protein-recognizing T cells in a model of progressive experimental autoimmune encephalomyelitis. Eur J Immunol 2001; 31: 527-38
8. Inaba K, Metlay JP, Crowley MT, Witmer-Pack M, Steinman RM. Dendritic cells as antigen presenting cells in vivo. Int Rev Immunol 1990; 6: 197-206
9. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811
10. Grabbe S, Kampgen E, Schuler G. Dendritic cells: Multi-lineal and multi-functional. Immunol Today 2000; 21: 431-33
11. Banchereau J. Dendritic cells: Therapeutic potentials. Transfus Sci 1997; 18: 313-26
12. Feili-Hariri M, Dong X, Alber SM, et al. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999; 48: 2300-308
13. Papaccio G, De Luca A, De Luca B, Pisanti FA, Zarrilli S. Detection of dendritic cells in the non-obese diabetic (NOD) mouse islet pancreas infiltrate is correlated with Th2-cytokine production. J Cell Biochem 1999; 74: 447-57
14. Papaccio G, Nicoletti F, Pisanti FA, Bendtzen K, Galdieri M. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 2000; 141: 1500-505
15. Xiao BG, Huang Y, Yang P, et al. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats. Clin Exp Immunol 2001; 125: 300-309
16. Huang YM, Yang JS, Xu LY, Link H, Xiao BG. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol 2000; 122: 437-44
17. Link H, Huang YM, Masterman T, Xiao BG. Vaccination with autologous dendritic cells: From experimental autoimmune encephalomyelitis to multiple sclerosis. J Neuroimmunol 2001; 114: 1-7
18. Murase N, Ichikawa N, Ye Q, et al. Dendritic cells/chimerism/alleviation of chronic allograft rejection. J Leukoc Biol 1999; 66: 297-300
19. Thomson AW, Lu L. Are dendritic cells the key to liver transplant tolerance? Immunol Today 1999; 20: 27-32
20. Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223: 77-92
21. Calida DM, Constantinescu C, Purev E, et al. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte peptide-induced experimental autoimmune encephalomyelitis in mice. J Immunol 2001; 166: 723-26
22. Zhang GX, Xu H, Kishi M, Calida D, Rostami AM. Reversal of spontaneous progressive autoimmune encephalomyelitis by myelin basic protein-induced clonal deletion. Autoimmunity 1999; 31: 219-27
23. Kapsenberg ML, Kalinski P. The concept of type 1 and type 2 antigen-presenting cells. Immunol Lett 1999; 69: 5-6
24. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52
25. Maldonado-Lopez R, De Smedt T, Michel P, et al. CD8alpha+ and CD8alpha-subclasses of dendritic cells direct the development of district T helper cells in vivo. J Exp Med 1999; 189: 587-92
26. Pulendran B, Smith JL, Caspray G, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999; 96: 1036-41
27. Vieira PL, De Jong EC, Wierenga EA, Kapsenberg ML, Kalinski P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000; 164: 4507-12
28. Tanaka H, Demeure CE, Rubio M, Delespesse G, Sarfati M. Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio. J Exp Med 2000; 192: 405-12
29. Kalinski P, Schuitemaker JH, Hilkens CM, Wierenga EA, Kapsenberg ML. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J Immunol 1999; 162: 3231-36
30. Dittel BN, Visintin I, Merchant RM, Janeway Jr CA. Presentation of the self-antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J Immunol 1999; 163: 32-39
31. Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000; 1: 199-205
32. Drakesmith H, Chain B, Beverley P. How can dendritic cells cause autoimmune disease? Immunol Today 2000; 21: 214-17
33. Chang JT, Segal BM, Shevach EM. Role of costimulation in the induction of the IL-12/IL-12 receptor pathway and the development of autoimmunity. J Immunol 2000; 164: 100-106
34. Segal BM, Dwyer BK, Shevach EM. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 1998; 187; 537-46
35. Nikcevich KM, Gordon KB, Tan L, et al. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol 1997; 158: 614-21
36. Willenborg DO, Fordham SA, Staykova MA, Ramshaw IA, Cowden WB. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide. J Immunol 1999; 163: 5278-86
37. Chu CQ, Wittmer S, Dalton DK. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 2000; 192: 123-28
38. Traugott U. Acute experimental autoimmune encephalomyelitis. Differences between T cell subsets in the blood and meningeal infiltrates in susceptible and resistant strains of guinea pigs. J Neurol Sci 1983; 61: 81-91
39. Cua DJ, Hinton DR, Stohlman SA. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol 1995; 155: 4052-59
40. Teuscher C, Hickey WF, Grafer CM, Tung KS. A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/c mice. J Immunol 1998; 160: 2751-56
41. Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996; 184: 19-29
42. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772-80
43. Cua DJ, LaFace DM. Stohlman SA, Coffman RL. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J Immunol 2001; 166: 602-608
44. Menges M, Robner S, Voigtlander C, et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002; 195: 15-21
45. Tuohy VK, Yu M, Yin L, et al. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. J Neuroimmunol 2000; 111: 55-63